CN113614101B - 淀粉样肽的变体 - Google Patents
淀粉样肽的变体 Download PDFInfo
- Publication number
- CN113614101B CN113614101B CN202080015845.1A CN202080015845A CN113614101B CN 113614101 B CN113614101 B CN 113614101B CN 202080015845 A CN202080015845 A CN 202080015845A CN 113614101 B CN113614101 B CN 113614101B
- Authority
- CN
- China
- Prior art keywords
- iapp
- asn
- hiapp
- leu
- artificial sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410844356.7A CN118955675A (zh) | 2019-02-22 | 2020-02-24 | Iapp肽、包含其的药物组合物及其应用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809167P | 2019-02-22 | 2019-02-22 | |
| US62/809,167 | 2019-02-22 | ||
| PCT/US2020/019557 WO2020172686A1 (en) | 2019-02-22 | 2020-02-24 | Amyloid peptide variants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410844356.7A Division CN118955675A (zh) | 2019-02-22 | 2020-02-24 | Iapp肽、包含其的药物组合物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113614101A CN113614101A (zh) | 2021-11-05 |
| CN113614101B true CN113614101B (zh) | 2024-07-16 |
Family
ID=72145021
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080015845.1A Active CN113614101B (zh) | 2019-02-22 | 2020-02-24 | 淀粉样肽的变体 |
| CN202410844356.7A Pending CN118955675A (zh) | 2019-02-22 | 2020-02-24 | Iapp肽、包含其的药物组合物及其应用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410844356.7A Pending CN118955675A (zh) | 2019-02-22 | 2020-02-24 | Iapp肽、包含其的药物组合物及其应用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12522635B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3927725A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7505713B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN113614101B (cg-RX-API-DMAC7.html) |
| IL (1) | IL285699A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020172686A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4136446B1 (en) * | 2020-05-19 | 2025-05-14 | EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt | Method for detecting amyloid aggregates in blood |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110402308A (zh) * | 2016-11-09 | 2019-11-01 | 可口可乐公司 | 生物基meg和聚酯纤维组合物以及其制造方法 |
| CN112225808A (zh) * | 2012-09-12 | 2021-01-15 | 生物控股有限公司 | 人胰岛淀粉样多肽(hiapp)特异性抗体及其用途 |
| CN112672755A (zh) * | 2018-06-15 | 2021-04-16 | 普罗克拉拉生物科学股份有限公司 | 通用淀粉样蛋白相互作用基序(gaim) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE454299B (sv) * | 1986-10-08 | 1988-04-18 | Westermark P | Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden |
| HU222249B1 (hu) | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5814600A (en) | 1991-05-24 | 1998-09-29 | Amylin Pharmaceuticals Inc. | Method and composition for treatment of insulin requiring mammals |
| US7060670B1 (en) | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| KR100994748B1 (ko) | 2002-04-19 | 2010-11-17 | 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 | 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물 |
| JP2007527365A (ja) | 2003-03-18 | 2007-09-27 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | アミリン凝集阻害剤およびその使用 |
| DE102004051014A1 (de) | 2004-10-20 | 2006-04-27 | Rwth Aachen | Chemisch modifizierte Peptidanaloga |
| GB0501348D0 (en) | 2005-01-24 | 2005-03-02 | Zyentia Ltd | Compositions and methods |
| WO2007114838A1 (en) * | 2006-03-31 | 2007-10-11 | Amylin Pharmaceuticals, Inc. | Amylin and amylin agonists for treating psychiatric diseases and disorders |
| EP2036923A1 (en) | 2007-09-11 | 2009-03-18 | Novo Nordisk A/S | Improved derivates of amylin |
| BR112013007442A2 (pt) | 2010-09-28 | 2019-09-24 | Amylin Pharmaceuticals Llc | polipeptídeos construídos tendo duração de ação realçada |
| US20130022620A1 (en) | 2011-06-09 | 2013-01-24 | Ann Marie Schmidt | Assays and methods pertaining to pre-amyloid intermediates |
| EP2718315B1 (en) | 2011-06-10 | 2017-12-27 | Novo Nordisk A/S | Pramlintide derivatives |
| WO2015062803A1 (en) | 2013-10-29 | 2015-05-07 | Kapurniotu Aphrodite | Modified segments of islet amyloid polypeptide |
| WO2018144671A1 (en) | 2017-02-01 | 2018-08-09 | The Research Foundation For The State University Of New York | Mutant islet amyloid polypeptides with improved solubility and methods for using the same |
-
2020
- 2020-02-24 JP JP2021549163A patent/JP7505713B2/ja active Active
- 2020-02-24 US US17/428,615 patent/US12522635B2/en active Active
- 2020-02-24 EP EP20759401.1A patent/EP3927725A4/en active Pending
- 2020-02-24 CN CN202080015845.1A patent/CN113614101B/zh active Active
- 2020-02-24 WO PCT/US2020/019557 patent/WO2020172686A1/en not_active Ceased
- 2020-02-24 CN CN202410844356.7A patent/CN118955675A/zh active Pending
-
2021
- 2021-08-18 IL IL285699A patent/IL285699A/en unknown
-
2024
- 2024-06-05 JP JP2024091172A patent/JP7825238B2/ja active Active
-
2025
- 2025-12-17 US US19/423,936 patent/US20260109744A1/en active Pending
-
2026
- 2026-02-13 JP JP2026021632A patent/JP2026094195A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112225808A (zh) * | 2012-09-12 | 2021-01-15 | 生物控股有限公司 | 人胰岛淀粉样多肽(hiapp)特异性抗体及其用途 |
| CN110402308A (zh) * | 2016-11-09 | 2019-11-01 | 可口可乐公司 | 生物基meg和聚酯纤维组合物以及其制造方法 |
| CN112672755A (zh) * | 2018-06-15 | 2021-04-16 | 普罗克拉拉生物科学股份有限公司 | 通用淀粉样蛋白相互作用基序(gaim) |
Non-Patent Citations (4)
| Title |
|---|
| Neşe Kurt等.The Burial of Solvent-Accessible Surface Area Is a Predictor of Polypeptide Folding and Misfolding as a Function of Chain Elongation.《Journal of the American chemical society》.2005,第127卷(第45期),第15690-15691页. * |
| Pollen,A.等.IAPP isoform 5, partial [Pan troglodytes].《Genbank database》.2018,Accession NO. PNI98857.1. * |
| Selection for Nonamyloidogenic Mutants of Islet Amyloid Polypeptide (IAPP) Identifies an Extended Region for Amyloidogenicity;Ayano Fox等;《Biochemistry》;第49卷(第36期);第7783–7789页 * |
| The Burial of Solvent-Accessible Surface Area Is a Predictor of Polypeptide Folding and Misfolding as a Function of Chain Elongation;Neşe Kurt等;《Journal of the American chemical society》;第127卷(第45期);第15690-15691页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20260109744A1 (en) | 2026-04-23 |
| JP2022521266A (ja) | 2022-04-06 |
| JP2026094195A (ja) | 2026-06-09 |
| CN113614101A (zh) | 2021-11-05 |
| EP3927725A1 (en) | 2021-12-29 |
| JP7505713B2 (ja) | 2024-06-25 |
| IL285699A (en) | 2021-10-31 |
| JP7825238B2 (ja) | 2026-03-06 |
| US20220119468A1 (en) | 2022-04-21 |
| WO2020172686A9 (en) | 2020-11-12 |
| CN118955675A (zh) | 2024-11-15 |
| EP3927725A4 (en) | 2023-06-14 |
| WO2020172686A1 (en) | 2020-08-27 |
| US12522635B2 (en) | 2026-01-13 |
| JP2024125307A (ja) | 2024-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4004022B1 (en) | Substances and methods for the treatment of Friedreich's disease | |
| EP4431522A1 (en) | Pharmaceutical composition of glp-1 receptor and gip receptor dual agonist, and use thereof | |
| JP2025090703A (ja) | 糖尿病の処置のためのペプチド | |
| CN107405382A (zh) | 用于改善认知的方法和组合物 | |
| US20260109744A1 (en) | Amyloid peptide variants | |
| KR20200003889A (ko) | C-말단 cdnf 및 manf 단편, 이를 포함하는 약학적 조성물 및 그 용도 | |
| US20100221240A1 (en) | Chemically Modified Peptide Analogs | |
| HUP0401612A2 (hu) | Cukorbetegség kezelésére alkalmas gyógyszerkészítmények | |
| JP7553115B2 (ja) | 糖尿病治療のためのペプチド断片 | |
| CN101300269A (zh) | 机械生长因子肽及其用途 | |
| WO2025017057A1 (en) | Peptides for use in the treatment of axonal damage in diabetes | |
| US20140303093A1 (en) | Micro-utrophin polypeptides and methods | |
| US20150166629A1 (en) | SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT | |
| KR20230054440A (ko) | 심근 손상의 치료 또는 예방에 사용하기 위한 펩타이드 | |
| JP2025509119A (ja) | 頭蓋脳損傷を治療する方法 | |
| HK40017988B (en) | Peptides for treatment of diabetes | |
| HK40017988A (en) | Peptides for treatment of diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |